Ionis Pharma (IONS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec9

U.S. Bank Raises Ionis Pharmaceuticals Target Price to $97

18:17

Dec4

Ionis Pharmaceuticals Director Sold Company Common Stock

00:01

Dec1

Ionis Pharmaceuticals Receives FDA Breakthrough Therapy Designation

12:01

Nov28

Ionis Pharmaceuticals Director Disposes of Company Common Stock

22:52

Ionis Pharmaceuticals EVP and CHRO Shannon L. Devers Sells Common Stock

22:52

Nov17

Ionis Pharmaceuticals Announces $700 Million Convertible Senior Notes Offering

21:07

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 156.72 M, Net Income -128.61 M, EPS -0.8049

Jul30

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 452.05 M, Net Income 123.55 M, EPS 0.7

Apr30

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 131.61 M, Net Income -146.94 M, EPS -0.9256

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More